ReviewPharmaceuticals (Basel, Switzerland)2024

Optimizing Outcomes: Bevacizumab with Carboplatin and Paclitaxel in 5110 Ovarian Cancer Patients-A Systematic Review and Meta-Analysis.

Yu Jin Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.